Who
James P. Flynn
Director
Company insider
Files Form 4 as: Director, Lite Strategy; Director, Synlogic; Director, Oruka Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 3
- Sells
- 0
- Bought
- $164K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 Dec 2022
- Last trade
- 24 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 25 Jun 2026 | LITS Lite StrategyBiotechnology | SEC FORM 4 Bought | $21K25,000 at $0.8555 | filing |
| 24 Jun 2026filed 25 Jun 2026 | LITS Lite StrategyBiotechnology | SEC FORM 4 Bought | $22K25,000 at $0.86 | filing |
| 19 Dec 2025filed 22 Dec 2025 | LITS Lite StrategyBiotechnology | SEC FORM 4 Bought | $98K70,000 at $1.40 | filing |
| 19 Nov 2025filed 20 Nov 2025 | LITS Lite StrategyBiotechnology | SEC FORM 4 Bought | $23K12,100 at $1.88 | filing |
| 14 Nov 2025filed 18 Nov 2025 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 | filing |
| 30 Sep 2025filed 2 Oct 2025 | LITS Lite StrategyBiotechnology | SEC FORM 4 Code A | $25K10,000 at $2.54 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 26 Apr 2025filed 29 Apr 2025 | SynlogicBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | LITS Lite StrategyBiotechnology | SEC FORM 4 Code A | $25K7,900 at $3.16 | filing |
| 19 Mar 2024filed 21 Mar 2024 | Synlogicoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 30 Jan 2024filed 31 Jan 2024 | ORKA Oruka Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 18 Dec 2023filed 12 Jan 2024 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,700 at $0.00 | filing |
| 18 Dec 2023filed 12 Jan 2024 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 18 Dec 2023filed 20 Dec 2023 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,700 at $0.00 | filing |
| 18 Dec 2023filed 20 Dec 2023 | LITS Lite Strategyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Dec 2022filed 19 Dec 2022 | ORKA Oruka Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
News
Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry ArchiveLITS · manilatimes.net · 13 Oct 2026
0 headlines in the last 90 days name James P. Flynn; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.